Insuficiencia cardíaca crónica
Tài liệu tham khảo
Ponikowski, 2016, 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, Eur J Heart Fail., 18, 891, 10.1002/ejhf.592
Imizcoz, 2008, Insuficiencia cardíaca Definición, fisiopatología y cambios estructurales, Cir Cardiov., 15, 15
Mann, 2015
Segovia Cubero, 2004, Etiología y evaluación diagnóstica en la insuficiencia cardíaca. Avances en el tratamiento de la insuficiencia cardíaca (II), Rev Esp Cardiol, 57, 250, 10.1016/S0300-8932(04)77097-9
Maggioni, 2013, EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot), Eur J Heart Fail, 15, 808, 10.1093/eurjhf/hft050
Gilbert, 2015, Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy, Lancet, 385, 2107, 10.1016/S0140-6736(14)61402-1
Hawkins, 2009, Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology, Eur J Heart Fail, 11, 130, 10.1093/eurjhf/hfn013
Hawkins, 2013, Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services, Eur Heart J., 34, 2795, 10.1093/eurheartj/eht192
Reddel, 2015, A summary of the new GINA strategy: a roadmap to asthma control, Eur Respir J., 46, 622, 10.1183/13993003.00853-2015
Khayat, 2015, Sleep disordered breathing and post-discharge mortality in patients with acute heart failure, Eur Heart J., 36, 1463, 10.1093/eurheartj/ehu522
Nakamura, 2015, Impact of sleep-disordered breathing and efficacy of positive airway pressure on mortality in patients with chronic heart failure and sleep-disordered breathing: a meta-analysis, Clin Res Cardiol, 104, 208, 10.1007/s00392-014-0774-3
Damman, 2014, Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis, Eur Heart J., 35, 455, 10.1093/eurheartj/eht386
Filippatos, 2014, Renal dysfunction and heart failure: things are seldom what they seem, Eur Heart J., 35, 416, 10.1093/eurheartj/eht515
Damman, 2015, The kidney in heart failure: an update, Eur Heart J., 36, 1437, 10.1093/eurheartj/ehv010
Manito, 2017, Documento de consenso de la Sociedad Española de Cardiología y la Sociedad Española de Medicina Interna sobre el diagnóstico y tratamiento del déficit de hierro en la insuficiencia cardíaca, Rev Clin Esp., 217, 35, 10.1016/j.rce.2016.08.001
Szachniewicz, 2003, Anaemia is an independent predictor of poor outcome in patients with chronic heart failure, Int J Cardiol, 90, 303, 10.1016/S0167-5273(02)00574-0
Horwich, 2002, Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure, J Am Coll Cardiol., 39, 1780, 10.1016/S0735-1097(02)01854-5
Priori, 2015, 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the Europe, Eur Heart J., 36, 2793, 10.1093/eurheartj/ehv316
Kirchof, 2016, 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, Eur Heart J., 37, 2893, 10.1093/eurheartj/ehw210
Desai, 2015, Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients, Eur Heart J., 36, 1990, 10.1093/eurheartj/ehv186
Brignole, 2013, 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC), Developed in collaboration with the European Heart Rhythm Association. Eur Heart J., 34, 2281
Hundley, 2010, ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the american college of cardiology foundation task force on expert consensus documents, Circulation., 121, 2462, 10.1161/CIR.0b013e3181d44a8f
Moon, 2013, Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement, J Cardiovasc Magn Reson, 15, 92, 10.1186/1532-429X-15-92
Jolicoeur, 2015, Importance of angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction: insights from STICH, J Am Coll Cardiol., 66, 2092, 10.1016/j.jacc.2015.08.882
Montalescot, 2013, 2013 ESC guidelines on the management of stable coronary artery disease, Eur Heart J., 34, 2949, 10.1093/eurheartj/eht296
Lupón, 2008, Patients’ self-care improvement with nurse education intervention in Spain assessed by the European Heart Failure Self-Care Behaviour Scale, Eur J Cardiovasc Nurs., 7, 16, 10.1016/j.ejcnurse.2007.05.004
McMurray, 2014, PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure, N Engl J Med, 371, 993, 10.1056/NEJMoa1409077
Garg, 1995, Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure, JAMA, 273, 1450, 10.1001/jama.1995.03520420066040
Willenheimer, 2005, Circulation, 112, 2426, 10.1161/CIRCULATIONAHA.105.582320
Packer, 2002, Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study, Circulation., 106, 2194, 10.1161/01.CIR.0000035653.72855.BF
Pitt, 2011, Eplerenone in patients with systolic heart failure and mild symptoms, N Engl J Med, 364, 11, 10.1056/NEJMoa1009492
Swedberg, 2010, Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study, Lancet., 376, 875, 10.1016/S0140-6736(10)61198-1
Fukuta, 2016, Effects of drug and exercise intervention on functional capacity and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials, Eur J Prev Cardiol, 23, 78, 10.1177/2047487314564729